Last updated: May 13, 2024
Sponsor: University of Oslo
Overall Status: Completed
Phase
N/A
Condition
Muscular Dystrophy
Treatment
Tyromotion Amadeo and Armeo Senso
Clinical Study ID
NCT05560438
256361
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Granted rehabilitation at Vikersund Rehabilitation center Genetical confirmedmyotonic dystrophy diagnosis MIRS score between 2-5
Exclusion
Exclusion Criteria:
- MIRS score on 1 Reduced Cognitive function and unable to participate intechnological rehabilitation and digital evaluation
Study Design
Total Participants: 6
Treatment Group(s): 1
Primary Treatment: Tyromotion Amadeo and Armeo Senso
Phase:
Study Start date:
January 03, 2022
Estimated Completion Date:
December 31, 2023
Connect with a study center
Vikersund Rehabilitation Center
Vikersund, Viken 3370
NorwaySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.